Circulatory shock research hub

A randomized double-blind placebo-controlled phase 1 study on the safety, tolerability and pharmacokinetics/-dynamics of escalating single intravenous doses of AK1967 (Procizumab) in healthy male volunteers

This study is testing a new medicine called AK1967 (Procizumab) in healthy men. It aims to see if the medicine is safe, how well the body handles it, and what it does in the body. This is a very early study, giving small doses for the first time in people.